Merus NV
NASDAQ:MRUS
Merus NV
Revenue
Merus NV
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Merus NV
NASDAQ:MRUS
|
Revenue
$43.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Pharming Group NV
AEX:PHARM
|
Revenue
$245.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
43%
|
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
Revenue
€9.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Uniqure NV
NASDAQ:QURE
|
Revenue
$15.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
argenx SE
XBRU:ARGX
|
Revenue
$1.2B
|
CAGR 3-Years
210%
|
CAGR 5-Years
121%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Revenue
€97.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Merus NV's Revenue?
Revenue
43.9m
USD
Based on the financial report for Dec 31, 2023, Merus NV's Revenue amounts to 43.9m USD.
What is Merus NV's Revenue growth rate?
Revenue CAGR 5Y
3%
Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Merus NV have been 14% over the past three years , 3% over the past five years .